-
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; methanesulfonic acid
-
ChemBase ID:
153264
-
Molecular Formular:
C17H20ClNO6S
-
Molecular Mass:
401.8618
-
Monoisotopic Mass:
401.06998605
-
SMILES and InChIs
SMILES:
CS(=O)(=O)O.c1cc(ccc1C1CNCCc2c1cc(c(c2Cl)O)O)O
Canonical SMILES:
CS(=O)(=O)O.Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O
InChI:
InChI=1S/C16H16ClNO3.CH4O3S/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21;1-5(2,3)4/h1-4,7,13,18-21H,5-6,8H2;1H3,(H,2,3,4)
InChIKey:
CVKUMNRCIJMVAR-UHFFFAOYSA-N
-
Cite this record
CBID:153264 http://www.chembase.cn/molecule-153264.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; methanesulfonic acid
|
|
|
IUPAC Traditional name
|
fenoldopam; methanesulfonic acid
|
|
|
Synonyms
|
6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol
|
Methanesulfonate
|
Corlopam
|
Fenoldopam Monomethanesulfonate
|
SKF 82526J
|
Fenoldopam Mesylate
|
Fenoldopam methanesulfonate
|
Fenoldopam mesylate
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.117505
|
H Acceptors
|
4
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-0.040907793
|
LogD (pH = 7.4)
|
1.2619835
|
Log P
|
1.9205202
|
Molar Refractivity
|
82.6847 cm3
|
Polarizability
|
31.639305 Å3
|
Polar Surface Area
|
72.72 Å2
|
Rotatable Bonds
|
1
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
SML0198
|
Biochem/physiol Actions Fenoldopam mesylate is a selective dopamine D1 receptor agonist used as an antihypertensive agent. It is an agonist for D1-like dopamine receptors and binds with moderate affinity to α2-adrenoceptors. It has no significant affinity for D2-like receptors, α1 and α-adrenoceptors, 5HT1 and 5HT2 receptors, or muscarinic receptors. Fenoldopam mesylate causes peripheral vasodilation by stimulating dopamine-1receptors and α2-adrenoceptors, increasing renal blood flow. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Weinstock, J., et al.: J. Med. Chem., 23, 973 (1980)
- • Stote, R.M., et al.: Clin. Pharmacol. Ther., 34, 309 (1980)
- • Carey, M., et al.: J. Clin. Invest., 74, 2198 (1980)
- • Caruana, M.P., et al.: Br. J. Clin. Pharmacol., 24, 721 (1980)
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent